News

For press inquiries contact us

BusinessWire

Interline Therapeutics Launches With $92 Million to Map and Correct Dysfunctional Protein Communities

May 13, 2021

Fierce Biotech

Foresite, Arch fuel $92M round for Interline Therapeutics, a biotech taking aim at protein communities

May 13, 2021

Biocentury

Interline: Correcting mutation-induced dysfunctional protein networks

May 13, 2021

Endpoints

After going down different drug discovery paths, Genentech vets reunite at Foresite Labs to map the ‘protein interactome’

May 13, 2021

Crunchbase

Interline Therapeutics Inks $92M For Drug Discovery

May 13, 2021

Outsourcing Pharma

Interline Therapeutics lands $92m to map, correct dysfunctional proteins

May 13, 2021

Med City

Backed by $92M, startup Interline aims to shed new light on protein communities

May 13, 2021

Genome Web

Interline Therapeutics Taking Protein Interaction-Based Approach to Drug Development

May 13, 2021